Risk of heart attack increases with six-month dual antiplatelet therapy
Patients who were given dual antiplatelet therapy (DAPT) for only six months doubled their risk of a heart attack compared with those treated for at least 12 months, according to research presented March 12, 2018 at the American College of Cardiologys 67th Annual Scientific Session in Orlando, Florida.
Read the full story.
Create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies